Die #1 Medizintourismusplattform seit 2014

Beste Immunhistochemie Diagnostiker - TOP-62 Ärzte

author
Der Inhalt entspricht den Redaktionsrichtlinien von Bookimed und wurde auf Qualität geprüft
Fahad Mawlood - Allgemeinarzt. Gewinner von 4 wissenschaftlichen Preisen. Er diente in Westasien. Ehemaliger Teamleiter eines medizinischen Teams zur Betreuung arabischsprachiger Patienten. Jetzt Fahad ist verantwortlich für die Datenverarbeitung und die Genauigkeit der medizinischen Inhalte.
image
Tural Pashayev
Hämatologe/-in
9 Jahre der Erfahrung
4.6
13 Rezensionen

Tural Pashayev

Hämatologe/-in
9 Jahre der Erfahrung
Aserbaidschan, das Baku
LIV Bona Dea Krankenhaus
4.6
13 Rezensionen
Arztbesuch preis auf anfrage
Thyreoidektomie $1500 - $3000
Prostatektomie $2000 - $4000
Mastektomie $720 - $4500
Weitere Behandlungen
image
Alandag Celal
Klinischer Onkologe/-in
15 Jahre der Erfahrung
5.0
1 Rezensionen

Alandag Celal

Klinischer Onkologe/-in
15 Jahre der Erfahrung
Türkei, Sivas
Medicana Sivas Hospital
image
Hilmi Apak
Pädiatrischer Hämatologe/-in
24 Jahre der Erfahrung
Türkei, Istanbul
Biruni University Hospital

Hilmi Apak

Pädiatrischer Hämatologe/-in
24 Jahre der Erfahrung
Dr. Hilmi Apak ist Facharzt für pädiatrische Hämatologie und Onkologie und verfügt über 21 Jahre Erfahrung in diesem Bereich. Er hat einen Spezialisierungsgrad in pädiatrischer Onkologie und hat verschiedene Operationen durchgeführt, darunter Knochenmarktransplantation, Leukämie-Chemotherapie und CAR-T-Zelltherapie. Dr. Apak hat 75 internationale medizinische Artikel veröffentlicht und war stellvertretender Herausgeber der Zeitschrift Turkish Pediatrics Archives.Mehr lesen
image
Nail Paksoy
Onkologe/Mammologe/-in
13 Jahre der Erfahrung
5.0
2 Rezensionen
Türkei, Istanbul
Medipol Bahçelievler Hospital

Nail Paksoy

Onkologe/Mammologe/-in
13 Jahre der Erfahrung

Akkredititationen:

ESMO Board Certification in Medical Oncology


PROFESSIONAL EXPERIENCE

2011-2012
Erzurum Koprukoyu State Hospital
Department: General Medicine

2012-2017
Istanbul University Cerrahpaşa Medical Faculty
Department: Internal Medicine

06/2017-10/2017
Istanbul Gaziosmanpasa Taksim Training and Research Hospital
Department: Internal Medicine

10/2017-11/2018
Istanbul University Istanbul Medical Faculty
Department: Allergy and Immunology Fellowship

2018/2022
Istanbul University Oncology Institute
Department: Medical Oncology Fellowship

2022-2023
Tekirdag City Hospital
Department: Medical Oncology Specialist

2023-present
Istanbul Medipol University Medipol Bahcelievler Private Hospital
Department: Medical Oncology Assoc. Prof.

 

EDUCATION

2005-2011
Medical Education
Sivas Cumhuriyet University Medical Faculty, Sivas, Turkey

2012-2017
Internal Medicine
Istanbul University Cerrahpaşa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey

2017-2018
Allergy-Immunology Fellowship
Istanbul University Istanbul Medical Faculty
Department of Internal Medicine, Division of Allergy and Immunology, Istanbul, Turkey

2018-2022
Medical Oncology Fellowship
Istanbul University Oncology Institute, Department of Medical Oncology, Istanbul, Turkey

2022
ESMO Board Certification in Medical Oncology
10th September 2022 in Paris, France.

2023
Medical Oncology Assoc. Prof.
Istanbul Medipol University Department of Medical Oncology, Istanbul, Turkey

 

INTERNATIONAL CLINICAL TRIALS:

1. Astefania - ROCHE

  • Title: A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
  • Role: Subinvestigator

2. PFİZER

  • Title: A Study Of Lorlatinib Versus Crizotinib In First-Line Treatment Of Patients With ALK-Positive NSCLC
  • Role: Subinvestigator

3. RECITE - AMGEN

  • Title: Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Gastrointestinal, Pancreatic, or Colorectal Cancer
  • Role: Subinvestigator

4. NAVIGATE - BAYER

  • Title: A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors
  • Role: Subinvestigator

5. RUBY - Tesaro (PRA)

  • Title: A Phase 3, Randomized, Double-blind, Multicenter Study of Dostarlimab (TSR-042) Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Patients With Recurrent or Primary Advanced Endometrial Cancer
  • Role: Subinvestigator

6. ENGOT-ov43/GOG-3036 - MSD

  • Title: Study of Chemotherapy With Pembrolizumab (MK-3475) Followed by Maintenance With Olaparib (MK-7339) for the First-Line Treatment of Women With BRCA Non-mutated Advanced Epithelial Ovarian Cancer (EOC) (MK-7339-001/KEYLYNK001/ENGOT-ov43/GOG-3036)
  • Role: Subinvestigator

7. ASTRA ZENECA

  • Title: To Study Clinical Effectiveness and Safety of Olaparib Monotherapy in Metastatic Breast Cancer Patients.
  • Role: Subinvestigator

8. ROSY-O - ASTRA ZENECA

  • Title: Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib
  • Role: Subinvestigator
  •  

INTERNATIONAL PUBLICATIONS

I. Published journal articles indexed by SCI, SSCI, and AHCI

Weekly Paclitaxel in Classic Kaposi Sarcoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Ahmed, M. A., Karaman, S., & Aydiner, A.
  • Journal: Medicine, 102(5)

Carboplatin Desensitization in Ovarian Carcinoma

  • Authors: Paksoy, N., Khanmammadov, N., Doğan, İ., Ferhatoğlu, F., Yildiz, A., Ak, N., & Aydiner, A.
  • Journal: Medicine, 101(45), e31726

High-Dose Chemotherapy for Ewing’s Sarcoma

  • Authors: Paksoy, N., Ferhatoglu, F., Dogan, İ., Khanmammadov, N., Celik, A. I., Gulbas, Z., & Başaran, M.
  • Journal: Medicine, 101(49), e32213

Multidrug Refractory TFE3(+) Renal Cell Carcinoma

  • Authors: Paksoy, Nail, et al.
  • Journal: Journal of Oncology Pharmacy Practice, 2022, 28.1: 215-221

Crizotinib Efficacy in NSCLC with MET Alterations

  • Authors: Gürbüz, M., Kiliçkap, S., Bilici, A., Karadurmuş, N., Sezer, A., Şendur, M. A. N., ... & Demirkazik, A.
  • Journal: Medicine, 101(50), e32368

Clinicopathological Features in ALK Mutant NSCLC

  • Authors: Dogan, I., Gurbuz, M., Paksoy, N., Ferhatoglu, F., Vatansever, S., Saip, P., ... & Aydiner, A.
  • Journal: Medicine, 101(34)

PSMA-Based Tumor Burden in Prostate Cancer

  • Authors: HAS SIMSEK, Duygu, et al.
  • Journal: Annals of Nuclear Medicine, 2021, 35.6: 680-690

Atezolizumab in Metastatic Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: European Urology Focus, 2021, 7.5: 1061-1066

Pulmonary Sarcomatoid Carcinoma

  • Authors: FERHATOGLU, Ferhat, et al.
  • Journal: Oncology Research and Treatment, 2021, 44.11: 590-601

Prognostic Factors in Atezolizumab-Treated Urothelial Carcinoma

  • Authors: TURAL, Deniz, et al.
  • Journal: International Journal of Clinical Oncology, 2021, 26.8: 1506-1513

Atezolizumab with Chemotherapy in Small Cell Lung Cancer

  • Authors: GÜRBÜZ, Mustafa, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 1-9

FOLFIRINOX vs. Gemcitabine + Nab-Paclitaxel in Pancreatic Cancer

  • Authors: AY, Seval, et al.
  • Journal: Journal of Chemotherapy, 2022, 1-7

Trastuzumab Emtansine in Older HER2-Positive Breast Cancer Patients

  • Authors: CIL, Ibrahim, et al.
  • Journal: Tumori Journal, 2022, 108.1: 19-25

Real-Life Efficacy of Osimertinib in Advanced NSCLC

  • Authors: HIZAL, Mutlu, et al.
  • Journal: Journal of Cancer Research and Clinical Oncology, 2022, 148.6: 1501-1508

ALK-Positive Cells Percentage and Alectinib Efficacy

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Atcı, M. M., Kahraman, S., Kılıçkap, S., ... & Şendur, M. A. N.
  • Journal: Journal of Cancer Research and Clinical Oncology, 149(8), 4141-4148

Real-World Data on Alectinib in ALK-Positive NSCLC

  • Authors: Hizal, M., Bilgin, B., Paksoy, N., Kılıçkap, S., Atcı, M. M., Kahraman, S., ... & Şendur, M. A. N.
  • Journal: Future Oncology, 18(23), 2573-2582

Prognostic Factors in Metastatic RCC with T790M Mutation

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Desensitization Protocol in Lenalidomide Hypersensitivity Reactions

  • Authors: DEMIR, Semra, et al.
  • Journal: Annals of Allergy, Asthma & Immunology, 2019, 123.4: 394-397

Factors Associated with Diagnostic Skin Test Positivity in PPI Hypersensitivity

  • Authors: ÖZDEMIR, Seçil Kepil, et al.
  • Journal: Allergy, 2019, 74.6: 1187-1190

Efficacy of Capecitabine and Temozolomide in Neuroendocrine Tumors

  • Authors: Ünal, Ç., Azizy, A., Karabulut, S., Taştekin, D., Akyıldız, A., Yaşar, S., ... & Sağlam, S.
  • Journal: The Oncologist, oyad257

Subsequent Treatments in Hormone-Positive Breast Cancer Progression

  • Authors: Karacin, C., Oksuzoglu, B., Demirci, A., Keskinkılıç, M., Baytemür, N. K., Yılmaz, F., ... & Hacıbekiroğlu, İ.
  • Journal: BMC cancer, 23(1), 192

Termination of Trastuzumab in HER2-Positive Metastatic Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Saip, P., & Aydiner, A.
  • Journal: Scientific Reports, 13(1), 8779

Long-term Outcomes and Predictors of Recurrence in Node-Negative Early Stage Breast Cancer

  • Authors: Dogan, I., Aydin, E., Khanmammadov, N., Paksoy, N., Ferhatoğlu, F., Ak, N., ... & Aydiner, A.
  • Journal: Journal of Cancer Research and Clinical Oncology, 1-9

Prognostic Factors Influencing PFS in HER2-Positive Metastatic Breast Cancer

  • Authors: Doğan, İ., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydıner, A.
  • Journal: European Journal of Breast Health, 19(2), 128

Treatment Efficacy of Ribociclib or Palbociclib plus Letrozole in Metastatic Breast Cancer

  • Authors: Kahraman, S., Erul, E., Seyyar, M., Gumusay, O., Bayram, E., Demirel, B. C., ... & Nahit Sendur, M. A.
  • Journal: Future Oncology, 19(10), 727-736

Efficacy and Safety of Sorafenib in Adult Metastatic Osteosarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Single-Agent Temozolomide as Salvage Therapy in Heavily Pretreated Metastatic Sarcoma Patients

  • Authors: Dogan, I., Paksoy, N., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

Outcomes and Prognostic Factors in Metastatic Renal Cell Carcinoma with Brain Metastases

  • Authors: Dogan, I., Iribas, A., Paksoy, N., Vatansever, S., & Basaran, M.
  • Journal: Journal of Cancer Research and Therapeutics

FLOT Regimen in First-Line Treatment of Metastatic Gastric Cancer

  • Authors: Tastekin, D., Paksoy, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., & Karabulut, S.
  • Journal: Journal of Cancer Research and Therapeutics

Prognostic Factors of Perioperative FLOT Regimen in Operable Gastric Cancer

  • Authors: Erol, C., Sakin, A., Basoglu, T., Ozden, E., Cabuk, D., Dogan, M., ... & Sendur, M. A. N.
  • Journal: [Not specified]

Efficacy and Outcomes of Systemic Chemotherapy in Posttransplant Kaposi Sarcoma

  • Authors: Khanmammadov, N., Paksoy, N., Doğan, I., Ferhatoğlu, F., Saip, P., & Aydiner, A.
  • Journal: Medicine, 102(39), e35383

Comparison of Second-Line Treatments in Metastatic Renal Cell Carcinoma

  • Authors: Pehlivan, M., Paksoy, N., Aydin, E., Basaran, M., & Ekenel, M.
  • Journal: Medicine, 102(41), e35245

Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study - Authors: Paksoy, N., Ferhatoğlu, F., Doğan, İ., Khanmammadov, N., Bozbey, H. U., Karabulut, S., & Taştekin, D. - Journal: TURKISH JOURNAL OF ONCOLOGY, 1(1)

Demographic and Clinical Features and Factors Associated with Survival in Patients with Primary Glomerulonephritis: Single Tertiary Center Experience - Authors: Paksoy, N., Trabulus, S., Seyahi, N., & Altiparmak, M. R. - Journal: Namik Kemal Tip Dergisi, 11(1)

Efficacy of Sorafenib in Symptomatic Patients with Pretreated Progressive Desmoid Tumors - Authors: Paksoy, N., Ferhatoglu, F., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M.

Nodal Response to Neoadjuvant Chemotherapy is a Better Predictive Factor of Survival Than Miller-Payne Scoring in Breast Cancer - Authors: Ak, Naziye, et al. - Journal: Journal of Oncological Sciences, 7.2: 42-49

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma - Authors: Ak, Naziye, et al. - Journal: Turkish Journal of Oncology/Türk Onkoloji Dergisi, 2021, 36.4

Identifying Risk Factors Associated with Survival and Drug-Related Toxicities in Imatinib-Resistant Gastrointestinal Stromal Tumor (GIST) Patients Treated with Sunitinib - Authors: Ferhatoglu, F., Karabulut, S., Paksoy, N., & Tastekin, D.

Real-life Outcomes of ROS1 Fusion-positive Metastatic Lung Cancer Patients who were Treated with Crizotinib - Authors: Dogan, İ., Khanmammadov, N., Paksoy, N., Ferhatoglu, F., Aydın, E., Vatansever, S., & Aydine, A. - Journal: TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY

Predictors of the acquisition of T790M mutation in EGFR-mutant metastatic lung cancer patients who were treated with EGFR inhibitors - Authors: Dogan, I., Khanmammadov, N., Paksoy, N., Vatansever, S., Saip, P., & Aydıner, A. - Journal: Eurasian Journal of Pulmonology

Laterality of Adrenal Gland Metastasis in Lung Cancer: Results of a Comparative Study - Authors: Ferhatoglu, F., Gagatay, T., Okumus, G., Aydiner, A., Paksoy, N., Ak, N., ... & Saip, P. - Journal: Eurasian Journal of Medical Investigation, 7(2)

Poor Risk Factors Affecting Cancer Patients Infected with Covid-19: A Retrospective Comparative Study from a Pandemic Hospital - Authors: Ferhatoglu, F., Kapağan, T., Paksoy, N., Ak, N., Medetalibeyoğlu, A., Şenkal, N., ... & Vatansever, S. - Journal: Turk Onkoloji Dergisi, 38(1)

Systemic Treatment Outcomes of Progressive Medullary Thyroid Carcinoma from the Registries of a Tertiary Cancer Center - Authors: Ferhatoglu, F., Paksoy, N., & Başaran, M. - Journal: Namik Kemal Tip Dergisi, 10(4)

Evaluation of clinical features and risk factors related to late recurrence (> 5 years) in patients with breast cancer - Authors: Ferhatoglu, F., Aydiner, A., & Paksoy, N. - Journal: Journal of Surgery & Medicine (JOSAM), 6(12)

Assessing the Clinical Impact of Lutetium-177 DOTATATE Peptide Receptor Radionuclide Therapy (PRRT) on Metastatic Neuroendocrine Tumors: A Multicenter Real-World Data from Türkiye

 

Thesis:

Istanbul University Cerrahpaşa Medical Faculty, Internal Medicine Department PAKSOY, Nail. Demographical, clinical characteristics and survival factors in patients withprimary glomerulonephritis: Cerrahpasa Medical Faculty Experience. (2016)

International Refereed Congress / Symposium Publications in Proceedings (ASCO/ESMO Abstracts)

Prognostic factors influencing progression-free survival in HER2 positive metastatic breast cancer patients who treated with lapatinib and capecitabine combination

  • Authors: Dogan, I., Paksoy, N., Ak, N., Vatansever, S., Saip, P., & Aydiner, A. (2022)

Efficacy of regorafenib and 5-fluorouracil-based rechallenge treatment in the third-line treatment of metastatic colorectal cancer: A Turkish oncology group study

  • Authors: Şenocak Taşçi, E., Oyan, B., Sonmez, O., Mutlu, A. U., Atcı, M. M., Oner, I., ... & Gulmez, A. (2022)

Long-term outcomes and predictors of recurrence in patients with early-stage node-negative breast cancer

  • Authors: Dogan, I., Aydin, E., Paksoy, N., Ferhatoglu, F., Ak, N., Ibis, K., ... & Aydiner, A. (2021)

Efficacy of temozolomide in pretreated patients with metastatic sarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in symptomatic patients with pretreated progressive desmoid tumors

  • Authors: Ferhatoglu, F., Paksoy, N., Dogan, I., Ak, N., Pehlivan, M., Ekenel, M., & Basaran, M. (2021)

Efficacy of sorafenib in heavily pretreated adult patients with metastatic osteosarcoma

  • Authors: Paksoy, N., Dogan, I., Ekenel, M., & Basaran, M. (2021)

Outcomes and prognostic factors in metastatic renal cell carcinoma patients with brain metastases

  • Authors: Dogan, İ., Iribas, A., Paksoy, N., Ekenel, M., Vatansever, S., & Basaran, M. (2021)

Association of response to first-line chemotherapy with the efficacy of atezolizumab in patients with metastatic urothelial carcinoma

  • Authors: Tural, D., Olmez, O. F., Sümbül, A. T., Artac, M., Ozhan, N., Akar, E., ... & Erman, M. (2021)

Safety and survival in adult women with platinum-sensitive relapsed BRCA mutant ovarian cancer: A study of patients in Olaparib Turkey Early Access Program—LynTurk study

  • Authors: Esin, E., Ahmed, M. A., Yıldırım, H. Ç., Mandel, N. M., Erdemoglu, E., Sari, M., ... & Paydas, S. (2023)

Atezolizumab in patients with metastatic urothelial carcinoma who have progressed after first-line chemotherapy: Results of real-life experiences

  • Authors: Tural, D., Ölmez, Ö. F., Sümbül, A. T., Artaç, M., Özhan, N., Akar, E., ... & Kılıçkap, S. (2021)

 

 

Mehr lesen
5.0
2 Rezensionen
Arztbesuch preis auf anfrage
Radiojodtherapie $5000 - $7000
Strahlentherapie bei Hirntumoren $4000 - $6000
Mastektomie $5000 - $7500
Weitere Behandlungen
image
Murat Sarikaya
Gastroenterologe/-in
20 Jahre der Erfahrung
5.0
2 Rezensionen
Türkei, Istanbul
Medipol Bahçelievler Hospital

Murat Sarikaya

Gastroenterologe/-in
20 Jahre der Erfahrung

Experience:

2022 - 

Medipol Bahçelievler

2021 - 2022

MEDIPOL UNIVERSITY SEFAKÖY HOSPITAL

2018 - 2020

İSTİNYE UNIVERSITY FACULTY OF MEDICINE

2014 - 2020

TOKAT STATE HOSPITAL

2010 - 2010

BINGOL STATE HOSPITAL

 

Education:

2021

MEDIPOL UNIVERSITY, GASTROTEROLOGY

2018

İSTINYE UNIVERSITY, INTERNAL DISEASES USA

2014

ANKARA TRAINING AND RESEARCH HOSPITAL, GASTROENTEROLOGY

2010

FIRAT UNIVERSITY, FACULTY OF MEDICINE/INTERNAL MEDICAL SCIENCES DEPARTMENT/INTERNAL MEDICINE DEPARTMENT

2004

FIRAT UNIVERSITY, FACULTY OF MEDICINE

 

A. International Peer-Reviewed Journal Articles:

Title: Fatal fulminant hepatitis B after withdrawal of entecavir treatment in a patient with HBeAg seroconversion.

  • Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Babalı Ayşegül, Çakal Başak
  • Journal: Acta Gastro-Enterologica Belgica
  • Year: 2012
  • Volume/Issue: (Kontrol No: 1206043)

Title: Acute gastric obstruction resulting from gallstone-induced bezoar.

  • Authors: Sarıkaya Murat, Koçak Erdem, Köklü Seyfettin, Akbal Erdem
  • Journal: The American Surgeon
  • Year: 2012
  • Volume/Issue: 78(12)
  • Page: 529
  • (Kontrol No: 1129707)

Title: Garlic-induced esophagitis.

  • Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
  • Journal: Acta Gastro-Enterologica Belgica
  • Year: 2013
  • Volume/Issue: 76(2)
  • Page: 262
  • (Kontrol No: 1131422)

Title: Association between Helicobacter pylori and liver-to-spleen ratio.

  • Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
  • Journal: European Journal of Gastroenterology & Hepatology
  • Year: 2013
  • Volume/Issue: 25(1)
  • Pages: 107-110
  • Citations: 7
  • DOI: 10.1097/MEG.0b013e3283590c10
  • (Kontrol No: 1131424)

Title: Crohn's disease masked by median arcuate ligament syndrome.

  • Authors: Bıyıkoğlu İbrahim, Sarıkaya Murat, Uysal Ramadan Selma, Ergül Bilal, Doğan Zeynal
  • Journal: Chinese Medical Journal
  • Year: 2013
  • Volume/Issue: 126 (14)
  • Page: 2798
  • Citations: 1
  • (Kontrol No: 1131477)

Title: Telaprevir and anemia: What we learned from the first three patients.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Scandinavian Journal of Infectious Diseases
  • Year: 2013
  • Volume/Issue: 45(7)
  • Page: 575-575
  • Citations: 2
  • DOI: 10.3109/00365548.2012.759271
  • (Kontrol No: 1129738)

Title: Magnesium and parathyroid hormone levels of patients using different proton pump inhibitors.

  • Authors: Sarıkaya Murat, Filik Levent, Ergul Bilal, Doğan Zeynal
  • Journal: Gastroenterology Nursing
  • Year: 2013
  • Volume/Issue: 36 (2)
  • Pages: 145-148
  • DOI: 10.1097/SGA.0b013e31828d3753
  • (Kontrol No: 1129715)

Title: Is topical pharyngeal anesthesia necessary in esophagogastroduodenoscopy in all unsedated patients?

  • Authors: Ergül Bilal, Sarıkaya Murat, Doğan Zeynal, Filik Levent, Bıyıkoğlu İbrahim
  • Journal: Digestive Endoscopy
  • Year: 2013
  • Volume/Issue: 25(1)
  • Pages: 90-91
  • Citations: 2
  • DOI: 10.1111/j.1443-1661.2012.01383.x
  • (Kontrol No: 1129879)

Title: Inpatient Care Of Hepatitis C: Applying The Four Pillars Model To The Hospital Setting.

  • Authors: Sarıkaya Murat, Filik Levent, Doğan Zeynal, Ergül Bilal
  • Journal: Gastroenterology Nursing
  • Year: 2013
  • Volume/Issue: 36(2)
  • Pages: 141-144
  • DOI: 10.1097/SGA.0b013e31828d33db
  • (Kontrol No: 1129712)

Title: "The "Bouveret's Syndrome" Case Resolved Without Necrotic Changes."

  • Authors: Bilal Ergül, Murat Sarıkaya, Zeynal Doğan, Sevda İdil, Tarkan Karakan, Abdullah Çetin Köseoğlu
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 725434
  • DOI: 10.1155/2013/725434
  • (Kontrol No: 1131423)

Title: Severe acute pancreatitis due to hypertriglyceridemia.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Bıyıkoğlu İbrahim
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 945902
  • DOI: 10.1155/2013/945902
  • (Kontrol No: 1131425)

Title: Gallstone Ileus Caused by Cholecystoenteric Fistula Demonstrated on Computed Tomography.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Sevda İdil
  • Journal: Case Reports in Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 652960
  • DOI: 10.1155/2013/652960
  • (Kontrol No: 1131426)

Title: Intestinal Perforation Due to Ingested Chicken Bone Mimicking Crohn's Disease.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 604820
  • DOI: 10.1155/2013/604820
  • (Kontrol No: 1131427)

Title: Acute pancreatitis induced by hypertriglyceridemia: A case-based review.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Turkish Journal of Gastroenterology
  • Year: 2013
  • Volume/Issue: 24(3)
  • Pages: 276-280
  • DOI: 10.4318/tjg.2013.0565
  • (Kontrol No: 1129727)

Title: An Unusual Complication of Endoscopic Retrograde Cholangiopancreatography: Severe Acute Pancreatitis Leading to Death.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent, Tarkan Karakan
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 658370
  • DOI: 10.1155/2013/658370
  • (Kontrol No: 1131475)

Title: A Rare Cause of Abdominal Pain: Mesenteric Panniculitis.

  • Authors: Sarıkaya Murat, Doğan Zeynal, Ergül Bilal, Filik Levent
  • Journal: Case Reports in Gastrointestinal Medicine
  • Year: 2013
  • Volume/Issue: 2013
  • Article ID: 925259
  • DOI: 10.1155/2013/925259
  • (Kontrol No: 1131476)

B. Contributions to Scientific Conferences:

Title: Suicidal poisonings in Turkey: demographic and clinical aspects.

  • Authors: Sarikaya M., Gunes A., Goksu E., Erdogan G., Ozen C., Kaya A.
  • Conference: 30th European Congress of Clinical Toxicology (EAPCCT)
  • Year: 2000
  • Abstract ID: P44
  • (Kontrol No: 1131478)

Title: A Rare Cause of Gastrointestinal Bleeding: Aortoenteric Fistula.

  • Authors: Doğan Zeynal, Sarıkaya Murat, Filik Levent, Ergül Bilal
  • Conference: World Congress of Gastroenterology
  • Year: 2013
  • Abstract ID: P1367
  • (Kontrol No: 1131479)
Mehr lesen
5.0
2 Rezensionen
Arztbesuch preis auf anfrage
Radiojodtherapie $5000 - $7000
Strahlentherapie bei Hirntumoren $4000 - $6000
Mastektomie $5000 - $7500
Weitere Behandlungen
image
Selime Aydogdu
Pädiatrischer Hämatologe/-in / Onkologe/-in
22 Jahre der Erfahrung
4.6
13 Rezensionen
Aserbaidschan, das Baku
LIV Bona Dea Krankenhaus

Selime Aydogdu

Pädiatrischer Hämatologe/-in / Onkologe/-in
22 Jahre der Erfahrung
Dr. Selime Aydogdu ist Expertin für pädiatrische Hämatologie und Onkologie. Sie hat es sich zur Aufgabe gemacht, das Bewusstsein für Krebsfrühsymptome bei Kindern zu schärfen.Mehr lesen
4.6
13 Rezensionen
Arztbesuch preis auf anfrage
Thyreoidektomie $1500 - $3000
Prostatektomie $2000 - $4000
Mastektomie $720 - $4500
Weitere Behandlungen
image
Savash Kansoy
Pädiatrischer Hämatologe/-in / Onkologe/-in
46 Jahre der Erfahrung
4.6
476 Rezensionen
Türkei, Istanbul
Anadolu Medical Center

Savash Kansoy

Pädiatrischer Hämatologe/-in / Onkologe/-in
46 Jahre der Erfahrung

Education

  • Ege Faculty of Medicine 1978
  • Specialization in Pediatrics 1982
  • Subspecialty Pediatric Oncology 2002 (EU Faculty of Medicine)
  • Pediatric Hematology and Oncology 2012 (EU Faculty of Medicine)
  • Deputy Chief of Clinic 1988 Tepecik EAH
  • Clinical Chief 1993 Tepecik EAH
  • Associate Professorship 1995
  • Professorship  2002
  • Ege U. Faculty of Medicine, faculty member 1998 – 2022
  • EU Faculty of Medicine Department of Pediatrics 2009-2018
  • Member of Tepecik Education Planning and Coordination Board (1993-1998)
  • SSI Tepecik Hospital Ethics Committee Chairman (1996-1998)
  • Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group Co-Chair" (2002-2006)
  • Turkish Society of Pediatric Hematology "Bone Marrow Transplantation Working Group" (2006-2008)
  • Turkish Society of Pediatric Hematology - Responsible for Bone Marrow Transplantation "Online" Data Registry System 2007-ongoing.
  • Ege University Regenerative Medicine and Stem Cell Commission Chairman, 2011-2021

Institutional Memberships

  • Turkish Medical Association İzmir and Kocaeli Branch
  • Turkish National Pediatric Association - İzmir
  • European Group for Bone Marrow Transplantation (EBMT); Ege University Pediatric Bone Marrow Transplantation Unit was accredited by the European Group for Bone Marrow Transplantation (EBMT) in June 2007.
  • Turkish Society of Pediatric Hematology - Board Member for two terms (2005-2009)
  • Turkish Society of Hematology - Board Member for two terms (2001/2005)
  • Turkish Pediatric Oncology Association
  • Bone Marrow Transplantation Foundation (KITVAK) Member of the Board of Trustees

Units he is the founder of                        

1- SSI Tepecik Hospital Pediatric Oncology Clinic (1990) 
2- SSI Tepecik Hospital Pediatric Bone Marrow Transplantation Unit (1992) 
3- EU Faculty of Medicine Pediatric Bone Marrow Transplantation Unit (1998) 
4- FOUNDER of JOURNAL OF PEDIATRIC RESEARCH, 2014; SCI application was made in 2022.  

Transplantation units that he contributed to the establishment of                        

1. İzmir BUÇH EAH Pediatric Bone Marrow Transplantation Unit (2019) 
2. Ümraniye EAH Pediatric Bone Marrow Transplantation Unit (2020) 
3. Kanuni Sultan Süleyman EAH Pediatric Bone Marrow Transplantation Unit (2020) (Transferred to Çam Sakura EAH)

Awards

  • Thrombotic parameters in bone marrow stem cell transplant patients, Pediatric Hematology Congress, Trabzon 2003
  • CD133 Antigen in Stem Cell: Pediatric Hematology Congress 2005. Research award
  • The role of Toll like receptors in febrile neutropenic patients, Best poster award. Turkish Hematology Congress 2008, Çeşme-İzmir
  • National pediatric stem cell transplantation activity- Oral presentation second prize, Turkish Hematology Society Stem Cell Transplantation Congress, 2022, Antalya

Publications

Kansoy S. "Bone Marrow and Stem Cell Transplantation Child Health and Diseases, 1st edition, EU Faculty of Medicine Printing House, 1999, İzmir

Kansoy S. Bone marrow transplantation in Thalassemia Major III. Aegean Thalassemia Days Book, 2000, Izmir

Kansoy S. Pediatric KIT Center Standards in Turkey. Childhood Acute Leukemias, Antalya 2000: 73-5

Kansoy S. Late Side Effects in Children. Special issue of Bone Marrow Transplantation Journal of Turkish Clinics. 2003

Kansoy S. Stem Cell Applications in Bone Marrow and Stem Cell Transplantation. Pediatric Oncology Nursing Course Book, İzmir, 2005

Kansoy S. Cord Blood as a Stem Cell Source. Stem Cell Special Issue. Turkey Clinics, 2008

Kansoy S. Stem Cell Transplantation in Lymphomas. General Pediatrics Book, Ed. Prof.Dr.Enver Hasanoglu, 2009

Kansoy S, Aksoylar S. Bone Marrow Transplantation in Children. Pediatrics, 2014 and 2017

Kansoy S. Rhabdomyosarcoma. Pediatrics, 2014 and 2017

Kansoy S. Approach to the child with cancer according to clinical findings. Pediatrics, 2014 and 2017 

11. Çetingül N, S.Kansoy, M.Kantar. Oncological Diseases. Pediatrics (Ed. A. Cura), 641-672, Ege University Print house, İzmir, 1999.  (1.05 points)

Kansoy S, M.Kantar. Head, Face and Eye Examination. Pediatric Prosthetic Physical Examination and Symptom Information (Ed. A.Cura)

Kantar M. Metabolic Emergency Problems in Oncology. Oncologic Emergencies and Supportive Care in Childhood (Ed. N. Çetingül, S. Kansoy), 15-24, Meta Basım, İzmir, 2003. 

Cord Blood Transplants in Turkey. HEMATOLOGIST, 2016

Kansoy S. Central Nervous System Tumors in Children Pediatrics, 2014 and 2017

Acute myeloblastic leukemia in children and its treatment. Pediatric Oncology Textbook, Poplack's Turkish, 2020

National pediatric stem cell transplant activity, 2020

Childhood stem cell transplantation indications, Turkey Clinics - International book 2020

In addition to the studies and papers in international journals published in large numbers, he is involved in international multicenter studies in some journals with high impact value.

Mehr lesen
4.6
476 Rezensionen
Arztbesuch preis auf anfrage
Strahlentherapie bei Gebärmutterhalskrebs $8000 - $15000
Operation bei Bauchspeicheldrüsenkrebs
Thyreoidektomie $7500 - $16000
Weitere Behandlungen
image
Murat Sari
Klinischer Onkologe/-in
8 Jahre der Erfahrung
5.0
2 Rezensionen
Türkei, Istanbul
Medipol Acibadem Bezirkskrankenhaus

Murat Sari

Klinischer Onkologe/-in
8 Jahre der Erfahrung

Education and Career


2011 – 2015, (Internal Medicine Specialist) Istanbul University Istanbul School of Education and Career

Medicine Department of Internal Medicine

2015 – 2016, (Internal Medicine) Specialist Istanbul Haydarpasa Numune Training and Research Hospital

2016 – 2019, (Medical Oncology) Istanbul University Istanbul School of Medicine Department of Medical Oncology

2019 – 2021, (Medical Oncology Specialist) - Istanbul Haydarpasa Numune Training and Research Hospital

2021 – 2024, (Associate Professor) Marmara University School of Medicine Department of Medical Oncology

Memberships in Scientific Organizations

ASCO

ESMO

TTOD 

AVOD 

Publications

In the field of oncology, he has published over 30 peer-reviewed articles at both international and national levels.

Awards Received

EAACI The European Academy of Allergy and Clinical Immunology 2019 Best Poster Award

"The top 3rd verbal presentation, IGICC (11th International Gastrointestinal Cancers Conference – IGICC2021)"

Speeches Delivered at National Congresses, Conferences, and Symposia:

 

Courses, Meetings, and Certificates

ESMO certified Medical Oncologist since 2019

Mehr lesen
image
Osman Kostek
Klinischer Onkologe/-in
20 Jahre der Erfahrung
5.0
2 Rezensionen
Türkei, Istanbul
Medipol Acibadem Bezirkskrankenhaus

Osman Kostek

Klinischer Onkologe/-in
20 Jahre der Erfahrung

Education

  • (2004 – 2011), Faculty of Medicine/ Inonu University/ Malatya, Turkiye
  • (2011 – 2015), Department of Radiology/ Bagcilar Training and Research Hospital/ Istanbul, Turkiye

Career

  • (2016 – 2020), Diagnostic and Interventional Radiologist/ Mus State Hospital/ Mus,Turkiye
  • (2020 – 2022), Assistant Professor of Diagnostic and Interventional Radiology/ Sakarya University Training and Research Hospital/ Sakarya, Turkiye
  • (2023 – 2024), Associate Professor of Diagnostic and Interventional Radiology /Sakarya University Training and Research Hospital/ Sakarya, Turkiye
  • (2024 - Present), Associate Professor of Diagnostic and Interventional Radiology /Medipol University Hospital/ Istanbul, Turkiye
Mehr lesen